Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Acta Crystallographica. Section C, Crystal Structure Communications
|
November 5, 2011
Comparison of racemic epi-inosose and (-)-epi-inosose
Shobhana Krishnaswamy, Madhuri T Patil, Mysore S Shashidhar
European Journal of Medicinal Chemistry
|
May 1, 2024
Structure-activity relationship in NOD2 agonistic muramyl dipeptides
Aarzoo Kamboj, Madhuri T Patil, Nikolai Petrovsky, et al.
RSC Advances
|
May 11, 2022
An efficient and scalable synthesis of potent TLR2 agonistic PAM<sub>2</sub>CSK<sub>4</sub>
Arshpreet Kaur, Poonam, Madhuri T Patil, et al.
Carbohydrate Research
|
April 30, 2025
Desymmetrization of myo-inositol
Nivedita T Patil, Madhuri T Patil, Rajesh G Gonnade, et al.
Bioorganic Chemistry
|
September 29, 2024
Simplified scalable synthesis of a water-soluble toll-like receptor 2 agonistic lipopeptide adjuvant for use with protein-based viral vaccines
Deshkanwar S Brar, Arshpreet Kaur, Madhuri T Patil, et al.
ACS Omega
|
July 15, 2024
Synthesis of Triazolo[4',5':4,5]furo[2,3-<i>c</i>]pyridine via Post Modification of an Unusual Groebke-Blackburn-Bienaymé Multicomponent Reaction
Aashima Batra, Manpreet Kaur, Deepender Kaushik, et al.
Journal of Medicinal Chemistry
|
May 14, 2024
Structure-Activity Relationships toward the Identification of a High-Potency Selective Human Toll-like Receptor-7 Agonist
Deepender Kaushik, Arshpreet Kaur, Madhuri T Patil, et al.
ACS Pharmacology & Translational Science
|
July 18, 2024
Design and Synthesis of Polyphenolic Imidazo[4,5-<i>c</i>]quinoline Derivatives to Modulate Toll Like Receptor-7 Agonistic Activity and Adjuvanticity
Kushvinder Kumar, Binita Sihag, Madhuri T Patil, et al.
Human Vaccines & Immunotherapeutics
|
April 17, 2020
BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
Deepender Kaushik, Simran Dhingra, Madhuri T Patil, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 22, 2023
Imidazo[2,1-b]thiazole based indoleamine-2,3-dioxygenase 1 (IDO1) inhibitor: Structure based design, synthesis, bio-evaluation and docking studies
Rahul Singh, Ravinder Kumar, Ashalata Roy, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Acta Crystallographica. Section C, Crystal Structure Communications
|
November 5, 2011
Comparison of racemic epi-inosose and (-)-epi-inosose
Shobhana Krishnaswamy, Madhuri T Patil, Mysore S Shashidhar
European Journal of Medicinal Chemistry
|
May 1, 2024
Structure-activity relationship in NOD2 agonistic muramyl dipeptides
Aarzoo Kamboj, Madhuri T Patil, Nikolai Petrovsky, et al.
RSC Advances
|
May 11, 2022
An efficient and scalable synthesis of potent TLR2 agonistic PAM<sub>2</sub>CSK<sub>4</sub>
Arshpreet Kaur, Poonam, Madhuri T Patil, et al.
Carbohydrate Research
|
April 30, 2025
Desymmetrization of myo-inositol
Nivedita T Patil, Madhuri T Patil, Rajesh G Gonnade, et al.
Bioorganic Chemistry
|
September 29, 2024
Simplified scalable synthesis of a water-soluble toll-like receptor 2 agonistic lipopeptide adjuvant for use with protein-based viral vaccines
Deshkanwar S Brar, Arshpreet Kaur, Madhuri T Patil, et al.
ACS Omega
|
July 15, 2024
Synthesis of Triazolo[4',5':4,5]furo[2,3-<i>c</i>]pyridine via Post Modification of an Unusual Groebke-Blackburn-Bienaymé Multicomponent Reaction
Aashima Batra, Manpreet Kaur, Deepender Kaushik, et al.
Journal of Medicinal Chemistry
|
May 14, 2024
Structure-Activity Relationships toward the Identification of a High-Potency Selective Human Toll-like Receptor-7 Agonist
Deepender Kaushik, Arshpreet Kaur, Madhuri T Patil, et al.
ACS Pharmacology & Translational Science
|
July 18, 2024
Design and Synthesis of Polyphenolic Imidazo[4,5-<i>c</i>]quinoline Derivatives to Modulate Toll Like Receptor-7 Agonistic Activity and Adjuvanticity
Kushvinder Kumar, Binita Sihag, Madhuri T Patil, et al.
Human Vaccines & Immunotherapeutics
|
April 17, 2020
BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
Deepender Kaushik, Simran Dhingra, Madhuri T Patil, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 22, 2023
Imidazo[2,1-b]thiazole based indoleamine-2,3-dioxygenase 1 (IDO1) inhibitor: Structure based design, synthesis, bio-evaluation and docking studies
Rahul Singh, Ravinder Kumar, Ashalata Roy, et al.
Page
of 2